Related Experiment Video
Updated: Aug 31, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Novel treatment for neuronopathic lysosomal storage diseases--cell therapy/gene therapy
1Department of Pediatrics, Institute for DNA Medicine, Tokyo Jikei University School of Medicine, Japan. yosh@sepia.ocn.ne.jp
Abstract:
Most lysosomal storage diseases (LSD) exhibit neurological symptoms and there has been limited success in their treatment. Innovative treatments employing novel therapy or gene therapy may offer the prospect of improvement. Recent attempts to treat the neurological forms of LSD include neural stem cell therapy, mesenchymal stem cell therapy, hematopoietic stem cell therapy and gene therapy. Additional approaches have included substrate deprivation/chaperone therapy for the treatment of LSD. This article reviews these new technologies, discusses recent progress, and suggests their possible application.
Related Concept Videos
Gene Therapy
Lysosomal Hydrolases
iPS Cell Differentiation
Microorganisms in Medicine and Therapeutics

